Denosumab for osteoporosis
Metadata[+] Show full item record
Denosumab (Prolia(R)) provides an alternative treatment for patients with osteoporosis that progresses despite bisphosphonate therapy, and for patients who cannot tolerate bisphosphonate therapy. Denosumab appears to be cost-effective compared with bisphosphonate therapy.
Evidence-based practice 14, no. 01 (2011): 01-02